Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study.
Antonios DourosSophie Dell'AnielloOriana Hoi Yun YuSamy SuissaPublished in: Diabetes, obesity & metabolism (2019)
Glimepiride was associated with a lower incidence of all-cause mortality compared with other second-generation sulphonylureas.